Form 4: Director Anthonie C. van Ekris Sells 1,115 Shares of Gabelli Healthcare & WellnessRx Trust

Director Anthonie C. van Ekris sold 1,115 shares of Gabelli Healthcare & WellnessRx Trust at a price of $9.65 per share on January 8, 2025.

Summary

• Anthonie C. van Ekris, a director of Gabelli Healthcare & WellnessRx Trust, sold 1,115 common shares of the company.
• The transaction occurred on January 8, 2025.
• The shares were sold at a price of $9.65 per share.
• Following the transaction, Mr. van Ekris directly owns 11,185 shares of the company.

Sentiment

Score: 5

Explanation: The document is a neutral disclosure of a share sale by a director, with no indication of positive or negative sentiment.

Industry Context

This is a routine disclosure of an insider transaction and does not necessarily indicate a broader trend in the healthcare and wellness sector.

Comparison to Industry Standards

• Insider trading disclosures are a standard practice for publicly traded companies, and this transaction is consistent with regulatory requirements.
• The sale of 1,115 shares by a director is a relatively small transaction and may not be indicative of broader trends in the company's performance or outlook.
• Comparable companies would also have similar disclosures when directors or officers trade shares.

Stakeholder Impact

• The share sale by a director may have a minor impact on shareholder sentiment, but the transaction is not large enough to significantly affect the share price.

Key Dates

Keywords

Gabelli Healthcare & WellnessRx Trust, GRX, insider trading, share sale, director, Anthonie C. van Ekris